Growth Metrics

Neogenomics (NEO) Total Debt (2016 - 2020)

Historic Total Debt for Neogenomics (NEO) over the last 12 years, with Q1 2020 value amounting to $95.6 million.

  • Neogenomics' Total Debt rose 185.05% to $95.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was $95.6 million, marking a year-over-year increase of 185.05%. This contributed to the annual value of $96.8 million for FY2019, which is 112.37% up from last year.
  • As of Q1 2020, Neogenomics' Total Debt stood at $95.6 million, which was up 185.05% from $96.8 million recorded in Q4 2019.
  • Neogenomics' 5-year Total Debt high stood at $99.3 million for Q3 2019, and its period low was $52.8 million during Q3 2016.
  • Over the past 5 years, Neogenomics' median Total Debt value was $78.2 million (recorded in 2017), while the average stood at $80.6 million.
  • As far as peak fluctuations go, Neogenomics' Total Debt surged by 4778.69% in 2017, and later plummeted by 1121.53% in 2018.
  • Over the past 5 years, Neogenomics' Total Debt (Quarter) stood at $73.9 million in 2016, then decreased by 4.78% to $70.4 million in 2017, then soared by 36.08% to $95.8 million in 2018, then increased by 1.12% to $96.8 million in 2019, then dropped by 1.26% to $95.6 million in 2020.
  • Its Total Debt stands at $95.6 million for Q1 2020, versus $96.8 million for Q4 2019 and $99.3 million for Q3 2019.